New hope for Tough-to-Treat lung cancer patients
NCT ID NCT05297890
Summary
This study is testing whether the drug lorlatinib can help control advanced lung cancer that has a specific genetic change called ROS1 and has worsened despite two prior standard treatments. It involves 70 patients in China who have already tried crizotinib and platinum chemotherapy. Researchers will measure how well the tumor shrinks and how long the benefit lasts, while monitoring side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED OR METASTATIC ROS1-POSITIVE NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing Cancer Hospital
Beijing, China
-
Cancer Hospital Chinese Academy of Medical Sciences
Beijing, China
-
Chinese PLA Army Medical Center
Chongqing, China
-
Fudan University Shanghai Cancer Center
Shanghai, China
-
Fujian Cancer Hospital
Fuzhou, China
-
Guangdong Provincial People's hospital
Guangzhou, Guangdong, 510080, China
-
Harbin Medical University Cancer Hospital
Harbin, China
-
Henan Cancer Hospital
Zhengzhou, China
-
Henan Provincial People's Hospital
Zhengzhou, China
-
Hunan Cancer Hospital
Changsha, China
-
Jiangsu Province Hospital
Nanjing, China
-
Liaoning Cancer Hospital and Institute
Shenyang, China
-
Shandong Cancer Hospital&Institute
Jinan, China
-
Shanghai Pulmonary Hospital
Shanghai, China
-
Shanxi Cancer hospital
Taiyuan, China
-
Sichuan Cancer Hospital & Institute
Chengdu, China
-
Sun Yat-sen University Cancer Center
Guangzhou, China
-
Tangdu Hospital of The fourth Military Medical University Peoples Liberation Army of China
Xi'an, China
-
The 1st Affiliated hospital of Wenzhou Medical University
Wenzhou, China
-
The First Affiliated Hospital of Anhui Medical University
Hefei, China
-
The First Affiliated Hospital of Nanchang University
Nanchang, China
-
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, China
-
The First Hospital of Jilin University
Changchun, China
-
The Second Affiliated Hospital of Nanchang University
Nanchang, China
-
The first Affiliated hospital, Sun Yat-Sen University
Guangzhou, China
-
Tianjin Medical University Cancer Institute & Hospital
Tianjin, China
-
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, China
-
West China Hospital of Sichuan University
Chengdu, China
-
Xiamen Humanity Hospital
Xiamen, China
-
Yunnan Cancer Hospital
Kunming, China
-
Zhejiang Cancer Hospital
Hangzhou, China
Conditions
Explore the condition pages connected to this study.